221 related articles for article (PubMed ID: 19125051)
1. Optimizing safety of selective internal radiation therapy (SIRT) of hepatic tumors with 90Y resin microspheres: a systematic approach to preparation and radiometric procedures.
Schleipman AR; Gallagher PW; Gerbaudo VH
Health Phys; 2009 Feb; 96(2 Suppl):S16-21. PubMed ID: 19125051
[TBL] [Abstract][Full Text] [Related]
2. Resin 90Y microsphere activity measurements for liver brachytherapy.
Dezarn WA; Kennedy AS
Med Phys; 2007 Jun; 34(6):1896-900. PubMed ID: 17654890
[TBL] [Abstract][Full Text] [Related]
3. Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method.
Ahmadzadehfar H; Haslerud T; Reichmann K; Meyer C; Habibi E; Fimmers R; Muckle M; Sabet A; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(3):95-8. PubMed ID: 24105253
[TBL] [Abstract][Full Text] [Related]
4. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
Welsh JS; Kennedy AS; Thomadsen B
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
[TBL] [Abstract][Full Text] [Related]
5. Quality assurance issues for therapeutic application of radioactive microspheres.
Dezarn WA
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S147-51. PubMed ID: 18406915
[TBL] [Abstract][Full Text] [Related]
6. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic).
Uthappa MC; Ravikumar R; Gupta A
Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750
[TBL] [Abstract][Full Text] [Related]
7. Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review.
Ho S; Lau WY; Leung TW; Johnson PJ
Cancer; 1998 Nov; 83(9):1894-907. PubMed ID: 9806647
[TBL] [Abstract][Full Text] [Related]
8. Development of activity standard for 90 Y microspheres.
Mo L; Avci B; James D; Simpson B; Van Wyngaardt WM; Cessna JT; Baldock C;
Appl Radiat Isot; 2005 Aug; 63(2):193-9. PubMed ID: 15963429
[TBL] [Abstract][Full Text] [Related]
9. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
Kennedy AS; Coldwell D; Nutting C; Murthy R; Wertman DE; Loehr SP; Overton C; Meranze S; Niedzwiecki J; Sailer S
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):412-25. PubMed ID: 16690429
[TBL] [Abstract][Full Text] [Related]
10. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
Konda A; Savin MA; Cappell MS; Duffy MC
Gastrointest Endosc; 2009 Sep; 70(3):561-7. PubMed ID: 19577743
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
[TBL] [Abstract][Full Text] [Related]
12. Radioassay of yttrium-90 radiation using the radionuclide dose calibrator.
Salako QA; DeNardo SJ
J Nucl Med; 1997 May; 38(5):723-6. PubMed ID: 9170436
[TBL] [Abstract][Full Text] [Related]
13. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
14. Selective internal radiation therapy-induced extrahepatic injury: an emerging cause of iatrogenic organ damage.
Crowder CD; Grabowski C; Inampudi S; Sielaff T; Sherman CA; Batts KP
Am J Surg Pathol; 2009 Jul; 33(7):963-75. PubMed ID: 18852678
[TBL] [Abstract][Full Text] [Related]
15. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
[TBL] [Abstract][Full Text] [Related]
16. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors.
Sarfaraz M; Kennedy AS; Cao ZJ; Sackett GD; Yu CX; Lodge MA; Murthy R; Line BR; Van Echo DA
Med Phys; 2003 Feb; 30(2):199-203. PubMed ID: 12607837
[TBL] [Abstract][Full Text] [Related]
17. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
[TBL] [Abstract][Full Text] [Related]
18. Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres.
Gulec SA; Siegel JA
J Nucl Med; 2007 Dec; 48(12):2080-6. PubMed ID: 18006608
[TBL] [Abstract][Full Text] [Related]
19. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721
[TBL] [Abstract][Full Text] [Related]
20. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
Gulec SA; Fong Y
Arch Surg; 2007 Jul; 142(7):675-82. PubMed ID: 17638807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
